Diabetes drugs might treat multiple myeloma
|
Tweet
|
|
In the lab, multiple myeloma cells are killed by drugs similar to existing anti-diabetes drugs like Avandia or Actos, according to researchers at the University of Rochester School of Medicine and Dentistry, New York.
Multiple myeloma is an uncommon cancer that arises in the bone marrow. Multiple myeloma cells express a receptor termed PPAR gamma, and so-called “glitazone” anti-diabetes drugs bind to this receptor.
"We have discovered that human multiple myeloma cells die in response to existing anti-diabetic drugs,” senior investigator Dr. Richard P. Phipps told Reuters Health. “Such drugs might prove useful to treating multiple myeloma, which is essentially incurable”.
In the medical journal Clinical Immunology, Phipps and his colleagues note that exposing multiple melanoma cells to a naturally occurring PPAR gamma-binding molecule triggered cell death.
This was also the case when the cells were treated with the diabetes drug ciglitazone. Other similar anti-diabetic drugs include rosiglitazone (Avandia) and pioglitazone (Actos).
The researchers also found that the action of the PPAR gamma-binding drugs was greatly enhanced by the presence of the vitamin A-like compound 9-cis retinoic acid.
Nevertheless, co-investigator Dr. Steven Bernstein stressed in a statement that further investigation of the action of glitazones is required “before clinical trials are warranted.”
SOURCE: Clinical Immunology, November 2004.
Revision date: June 18, 2011
Last revised: by Amalia K. Gagarina, M.S., R.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

